News Johnson & Johnson Sao Paulo

Equities

JNJB34

BRJNJBBDR002

Market Closed - Sao Paulo Other stock markets 01:35:00 04/06/2024 am IST			5-day change	1st Jan Change
51.6 ^BRL	+0.39%		+1.55%	+2.38%

02:36am	J&J must pay $260 million in latest talc trial, Oregon jury says	RE
03/06	Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

J&J must pay $260 million in latest talc trial, Oregon jury says	06:06am	RE
Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses	04/06	MT
Johnson & Johnson Announces Data from the Phase 3 PERSEUS Study	04/06	CI
Johnson & Johnson Announces New Data from the Phase 2 PALOMA-2 Study Evaluating Subcutaneous (SC) Amivantamab Combined with Lazertinib as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer	04/06	CI
Johnson & Johnson Completes Acquisition of Shockwave Medical	03/06	AQ
Johnson & Johnson - First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related reactions with five-minute subcutaneous amivantamab administration	03/06	AQ
J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO	03/06	RE
J&J-backed Rapport Therapeutics seeks to raise $144 mln in US IPO	03/06	RE
GSK blood cancer drug nearly halves risk of death in late-stage trial	02/06	RE
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	01/06	RE
Johnson & Johnson Announces First Data from the Phase 3 PALOMA-3 Study Evaluating Subcutaneous (SC) Amivantamab Combined with Lazertinib	01/06	CI
Sector Update: Health Care Stocks Higher Late Afternoon	01/06	MT
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	01/06	RE
Sector Update: Health Care Stocks Advance Friday Afternoon	31/05	MT
Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars	31/05	MT
Johnson & Johnson Executive Vice President, William N. Hait, M.D., Ph.D., to Retire, Effective September 2024	31/05	AQ
J&J: completes acquisition of Shockwave Medical	31/05	CF
Johnson & Johnson Closes Acquisition of Shockwave Medical	31/05	MT
Johnson & Johnson Completes Acquisition of Shockwave Medical	31/05	MT
Johnson & Johnson Completes Acquisition of Shockwave Medical	31/05	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST